Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Smitty2000on Nov 29, 2017 6:15pm

70 Views

Post# 27058674

RE:RE:RE:RE:RE:RE:RE:RE:FDA announces comprehensive regenerative medicine policy

are you saying that the application has not even been submitted?
sernova has been around the .25 sp for close to 5 years now. dr toleikis has so far failed miserably is his role. one of his most important responsibilities is to create shareholder value.
where is the value dr.?

wwmeinc wrote: You are not interested in knowing how the animal studies turned out BNF? As for trips to California in the winter time,I thought all Canadians head down that way to get away from the winter cold and maybe get in a game or two of golf?

Sorry BNF,I prefer to have some 'skin' in the game instead of pretending to have an interest in a company.

****Whether ViaCyte,Diabetecell(or whatever they call themselves) or now Encellin produce a device that works is really besides the point for me right now...because SVA is supposed to be top dog in this science and as top dog there are always others trying to over-take them.

I do not believe the silence from the company is helpful in any sense of the word. If they have interim animal study results then share them with all shareholders to keep them in the loop in the most open way possible but maybe you are right,the phone chats were a better way to communicate to shareholders and the like. Just like updating shareholders on why they still have not submitted an IND application to the FDA. The 0.24cts shareprice today is flat on the yr which points to no progress. Maybe in your 'books' it is a winner. GLTA